» Articles » PMID: 7926722

The DCC Gene Product in Cellular Differentiation and Colorectal Tumorigenesis

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 1994 May 15
PMID 7926722
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The analysis of human colorectal tumors has revealed frequent loss of heterozygosity (LOH) of the long arm of chromosome 18. A novel gene, DCC (deleted in colorectal cancer), located within the region of LOH on chromosome 18q was identified and has been implicated as a tumor suppressor gene. We have now shown that DCC encodes a membrane-bound protein of the immunoglobulin-CAM family, as demonstrated by cell-surface labeling, immunohistochemical analysis, and sequencing of cDNA clones. The DCC protein was found in axons of the central and peripheral nervous system and in differentiated cell types of the intestine. Colorectal tumors that lost their capacity to differentiate into mucus producing cells uniformly lacked DCC expression and loss of a chromosome 18q allele was often accompanied by loss of DCC expression in colon tumors. These results provide evidence that DCC encodes a cell surface-localized protein and emphasize the inverse relationship between differentiation and tumorigenesis.

Citing Articles

Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.

Hirai R, Kinugasa H, Yamamoto S, Ako S, Tsutsumi K, Abe M Br J Cancer. 2024; 130(10):1725-1731.

PMID: 38538728 PMC: 11091138. DOI: 10.1038/s41416-024-02654-2.


Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer.

Burkitt K Cancers (Basel). 2023; 15(19).

PMID: 37835379 PMC: 10571524. DOI: 10.3390/cancers15194685.


Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.

Kasprzak A Cancers (Basel). 2023; 15(18).

PMID: 37760539 PMC: 10526446. DOI: 10.3390/cancers15184570.


Somatic mutations in DCC are associated with genomic instability and favourable outcomes in melanoma patients treated with immune checkpoint inhibitors.

Li Y, Wang Q, Chen Y, Zhao L Br J Cancer. 2022; 127(8):1411-1423.

PMID: 35871235 PMC: 9553921. DOI: 10.1038/s41416-022-01921-4.


Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study.

Yan C, Yang H, Chen L, Liu R, Shang W, Yuan W BMC Cancer. 2021; 21(1):1286.

PMID: 34852768 PMC: 8638428. DOI: 10.1186/s12885-021-09031-9.